CTBP1 and melanoma: β-ARs are expressed on multiple malignant cell types and treatment with propranolol has been reported to reduce viability, and in some cases induce apoptosis, of cancer cell lines including pancreatic, gastric, leukemia, melanoma, and oral squamous cell carcinoma [12-14,17,18,41].